A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses

A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses

Our understanding of the immune responses that follow SARS-CoV-2 infection and vaccination has progressed considerably since the COVID-19 pandemic was first declared on the 11th of March in 2020. Recovery from infection is associated with the development of protective immune responses, although over...

Full description

Bibliographic Details
Main Authors:	Joseph Torresi, Melissa A. Edeling, Terry Nolan, Dale I. Godfrey
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 neutralizing antibody SARS-CoV-2 omicron vaccines immune imprinting
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.914167/full

Similar Items

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
by: Daniele Lapa, et al.
Published: (2022-05-01)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022-11-01)

Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis
by: Huichun Shi, et al.
Published: (2023-11-01)

The SARS-CoV-2 Variant Omicron Is Able to Escape Vaccine-Induced Humoral Immune Responses, but Is Counteracted by Booster Vaccination
by: Florian D. Hastert, et al.
Published: (2022-05-01)

Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model
by: Pia Gattinger, et al.
Published: (2024-02-01)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
by: Ailan Xu, et al.
Published: (2022-09-01)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
by: Yuntao Zhang, et al.
Published: (2022-07-01)

Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
by: Ali A. Rabaan, et al.
Published: (2023-03-01)

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants
by: Yudi Xie, et al.
Published: (2022-09-01)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
by: Tao Li, et al.
Published: (2023-12-01)

Effect of Third and Fourth mRNA-Based Booster Vaccinations on SARS-CoV-2 Neutralizing Antibody Titer Formation, Risk Factors for Non-Response, and Outcome after SARS-CoV-2 Omicron Breakthrough Infections in Patients on Chronic Hemodialysis: A Prospective Multicenter Cohort Study
by: Frank-Peter Tillmann, et al.
Published: (2022-06-01)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
by: Ye-Fan Hu, et al.
Published: (2022-02-01)

Monovalent XBB.1.5 booster vaccination induces a broad spectrum of SARS-CoV-2 neutralizing antibodies
by: Nan Huo, et al.
Published: (2024-12-01)

Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
by: Kristin Widyasari, et al.
Published: (2023-08-01)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
by: Jing Wang, et al.
Published: (2023-04-01)

Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
by: David Niklas Springer, et al.
Published: (2022-10-01)

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
by: Thomas Lechmere, et al.
Published: (2022-04-01)

The emergence of new variants and sub-variants of SARS-CoV-2 and the effectiveness of vaccines
by: Emad Behboudi, et al.
Published: (2023-02-01)

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations
by: Hak-Jun Hyun, et al.
Published: (2023-08-01)

Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
by: María I. Zapata-Cardona, et al.
Published: (2022-12-01)

Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant
by: Xiaoling Yu, et al.
Published: (2022-02-01)

Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
by: Maeva Katzmarzyk, et al.
Published: (2023-11-01)

Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant
by: Zhongcheng Zhou, et al.
Published: (2022-06-01)

A novel mRNA vaccine, SYS6006, against SARS-CoV-2
by: Ke Xu, et al.
Published: (2023-01-01)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
by: Francesca Dapporto, et al.
Published: (2022-11-01)

SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
by: Alina Seidel, et al.
Published: (2023-04-01)

Serum neutralizing antibody following the vaccination of inactivated SARS-CoV-2 vaccines
by: FU Chunyan, et al.
Published: (2023-09-01)

Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia
by: Diego A. Álvarez-Díaz, et al.
Published: (2022-12-01)

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
by: Xun Wang, et al.
Published: (2022-12-01)

Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray
by: David Niklas Springer, et al.
Published: (2024-01-01)

Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
by: Silvia Sutandhio, et al.
Published: (2023-07-01)

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination
by: Nungruthai Suntronwong, et al.
Published: (2022-07-01)

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
by: Linhui Hao, et al.
Published: (2023-02-01)

Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
by: J. Torresi, et al.
Published: (2024-04-01)

Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2
by: Peng Yu, et al.
Published: (2024-03-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
by: Krystallenia Paniskaki, et al.
Published: (2022-10-01)

Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2
by: Xiuqiong Bi, et al.
Published: (2022-04-01)

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
by: Jingwen Ai, et al.
Published: (2022-12-01)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
by: Rie Midorikawa, et al.
Published: (2022-05-01)